SIMILAR PATTERNS OF AMINO ACIDS FOR 1DSD_C_DVAC2_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1a5f | MONOCLONALANTI-E-SELECTIN 7A9ANTIBODY (HEAVYCHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 124PRO H 154THR H 123PRO H 125 | None | 1.35A | 1dsdC-1a5fH:undetectable | 1dsdC-1a5fH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1cl7 | PROTEIN (IGG1ANTIBODY 1696(VARIABLE HEAVYCHAIN))PROTEIN (IGG1ANTIBODY 1696(CONSTANT HEAVYCHAIN)) (Mus musculus;Mus musculus) |
PF07686(V-set)PF07654(C1-set) | 4 | THR H 116PRO H 118THR H 117PRO I 154 | None | 1.35A | 1dsdC-1cl7H:undetectable | 1dsdC-1cl7H:7.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1cl7 | PROTEIN (IGG1ANTIBODY 1696(VARIABLE HEAVYCHAIN))PROTEIN (IGG1ANTIBODY 1696(CONSTANT HEAVYCHAIN)) (Mus musculus;Mus musculus) |
PF07686(V-set)PF07654(C1-set) | 4 | THR H 117PRO I 154THR H 116PRO H 118 | None | 1.25A | 1dsdC-1cl7H:undetectable | 1dsdC-1cl7H:7.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ct8 | 7C8 FAB FRAGMENT LONG CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 116PRO B 118THR B 117PRO B 147 | None | 1.32A | 1dsdC-1ct8B:undetectable | 1dsdC-1ct8B:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eo8 | ANTIBODY (HEAVYCHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 147THR H 116PRO H 118 | None | 1.30A | 1dsdC-1eo8H:undetectable | 1dsdC-1eo8H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1f3d | CATALYTIC ANTIBODY4B2 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 125PRO H 155THR H 124PRO H 126 | None | 1.34A | 1dsdC-1f3dH:undetectable | 1dsdC-1f3dH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ghf | ANTI-ANTI-IDIOTYPEGH1002 FAB FRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 118PRO H 120THR H 119PRO H 149 | None | 1.31A | 1dsdC-1ghfH:undetectable | 1dsdC-1ghfH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ghf | ANTI-ANTI-IDIOTYPEGH1002 FAB FRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 119PRO H 149THR H 118PRO H 120 | None | 1.25A | 1dsdC-1ghfH:undetectable | 1dsdC-1ghfH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1il1 | MONOCLONAL ANTIBODYG3-519 (HEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR A 124PRO A 126THR A 125PRO A 155 | None | 1.35A | 1dsdC-1il1A:undetectable | 1dsdC-1il1A:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1il1 | MONOCLONAL ANTIBODYG3-519 (HEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR A 125PRO A 155THR A 124PRO A 126 | None | 1.32A | 1dsdC-1il1A:undetectable | 1dsdC-1il1A:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kwg | BETA-GALACTOSIDASE (Thermusthermophilus) |
PF02449(Glyco_hydro_42)PF08532(Glyco_hydro_42M)PF08533(Glyco_hydro_42C) | 4 | THR A 75PRO A 72THR A 73PRO A 76 | None | 1.32A | 1dsdC-1kwgA:undetectable | 1dsdC-1kwgA:2.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ngq | N1G9 (IGG1-LAMBDA) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 123PRO H 125THR H 124PRO H 154 | None | 1.23A | 1dsdC-1ngqH:undetectable | 1dsdC-1ngqH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ngq | N1G9 (IGG1-LAMBDA) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 124PRO H 154THR H 123PRO H 125 | None | 1.16A | 1dsdC-1ngqH:undetectable | 1dsdC-1ngqH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q0y | FAB 9B1, HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 116PRO H 118THR H 117PRO H 149 | None | 1.32A | 1dsdC-1q0yH:undetectable | 1dsdC-1q0yH:11.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1q0y | FAB 9B1, HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 149THR H 116PRO H 118 | None | 1.27A | 1dsdC-1q0yH:undetectable | 1dsdC-1q0yH:11.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qfu | PROTEIN(IMMUNOGLOBULINIGG1-KAPPA ANTIBODY(HEAVY CHAIN)) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 147THR H 116PRO H 118 | None | 1.31A | 1dsdC-1qfuH:undetectable | 1dsdC-1qfuH:7.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qgc | PROTEIN(IMMUNOGLOBULINHEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR A 123PRO A 125THR A 124PRO A 154 | None | 1.25A | 1dsdC-1qgcA:undetectable | 1dsdC-1qgcA:6.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1qgc | PROTEIN(IMMUNOGLOBULINHEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR A 124PRO A 154THR A 123PRO A 125 | None | 1.18A | 1dsdC-1qgcA:undetectable | 1dsdC-1qgcA:6.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rfd | FAB M82G2, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 149THR H 116PRO H 118 | None | 1.35A | 1dsdC-1rfdH:undetectable | 1dsdC-1rfdH:9.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rih | HEAVY CHAIN OFANTIBODY 14F7 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 147THR H 116PRO H 118 | None | 1.32A | 1dsdC-1rihH:undetectable | 1dsdC-1rihH:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1rur | IMMUNOGLOBULIN 13G5,HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 149THR H 116PRO H 118 | None | 1.35A | 1dsdC-1rurH:undetectable | 1dsdC-1rurH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a77 | IMMUNOGLOBULIN HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 127PRO H 157THR H 126PRO H 128 | None | 1.33A | 1dsdC-2a77H:undetectable | 1dsdC-2a77H:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ck0 | PROTEIN(IMMUNOGLOBULIN HEAVY CHAIN) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 121PRO H 151THR H 120PRO H 122 | None | 1.30A | 1dsdC-2ck0H:undetectable | 1dsdC-2ck0H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fd6 | H CHAIN OF FAB OFATN-615 ANTI-UPARANTIBODY (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 116PRO H 118THR H 117PRO H 142 | None | 1.34A | 1dsdC-2fd6H:undetectable | 1dsdC-2fd6H:14.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fd6 | H CHAIN OF FAB OFATN-615 ANTI-UPARANTIBODY (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 142THR H 116PRO H 118 | None | 1.27A | 1dsdC-2fd6H:undetectable | 1dsdC-2fd6H:14.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gjz | CATALYTICELIMINATION ANTIBODY13G5 HEAVY CHAIN (Mus musculus) |
no annotation | 4 | THR H 116PRO H 118THR H 117PRO H 149 | None | 1.35A | 1dsdC-2gjzH:undetectable | 1dsdC-2gjzH:8.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gjz | CATALYTICELIMINATION ANTIBODY13G5 HEAVY CHAIN (Mus musculus) |
no annotation | 4 | THR H 117PRO H 149THR H 116PRO H 118 | None | 1.29A | 1dsdC-2gjzH:undetectable | 1dsdC-2gjzH:8.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jel | JEL42 FAB FRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 116PRO H 118THR H 117PRO H 149 | None | 1.34A | 1dsdC-2jelH:undetectable | 1dsdC-2jelH:6.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2jel | JEL42 FAB FRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 149THR H 116PRO H 118 | None | 1.27A | 1dsdC-2jelH:undetectable | 1dsdC-2jelH:6.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ok0 | FAB ED10 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 149THR H 116PRO H 118 | None | 1.33A | 1dsdC-2ok0H:undetectable | 1dsdC-2ok0H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2op4 | MURINE ANTIBODY FABRS2-1G9 IGG1 HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 116PRO H 118THR H 117PRO H 149 | None | 1.34A | 1dsdC-2op4H:undetectable | 1dsdC-2op4H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2op4 | MURINE ANTIBODY FABRS2-1G9 IGG1 HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 149THR H 116PRO H 118 | None | 1.25A | 1dsdC-2op4H:undetectable | 1dsdC-2op4H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2oz4 | FAB FRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 118PRO H 148THR H 117PRO H 119 | None | 1.27A | 1dsdC-2oz4H:undetectable | 1dsdC-2oz4H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q09 | IMIDAZOLONEPROPIONASE (unidentified) |
PF01979(Amidohydro_1) | 4 | THR A 16PRO A 66THR A 65PRO A 14 | None | 1.31A | 1dsdC-2q09A:undetectable | 1dsdC-2q09A:3.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q8b | 1F9 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 115PRO H 117THR H 116PRO H 146 | None | 1.25A | 1dsdC-2q8bH:undetectable | 1dsdC-2q8bH:6.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2q8b | 1F9 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 116PRO H 146THR H 115PRO H 117 | None | 1.21A | 1dsdC-2q8bH:undetectable | 1dsdC-2q8bH:6.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r1y | FAB, ANTIBODYFRAGMENT (IGG1K),HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 115PRO B 145THR B 114PRO B 116 | None | 1.29A | 1dsdC-2r1yB:undetectable | 1dsdC-2r1yB:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w9d | ICSM 18-ANTI-PRPTHERAPEUTIC FABHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 120PRO H 149THR H 119PRO H 121 | None | 1.31A | 1dsdC-2w9dH:undetectable | 1dsdC-2w9dH:13.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ymx | FAB ANTIBODY HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 128PRO H 158THR H 127PRO H 129 | None | 1.31A | 1dsdC-2ymxH:undetectable | 1dsdC-2ymxH:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3bqu | 3H6 FAB HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR D 126PRO D 158THR D 125PRO D 127 | None | 1.35A | 1dsdC-3bquD:undetectable | 1dsdC-3bquD:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d9a | HEAVY CHAIN OFHYHEL10 ANTIBODYFRAGMENT (FAB) (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 417PRO H 447THR H 416PRO H 418 | THR H 417 ( 0.8A)PRO H 447 ( 1.1A)THR H 416 ( 0.8A)PRO H 418 ( 1.1A) | 1.33A | 1dsdC-3d9aH:undetectable | 1dsdC-3d9aH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i75 | ANTIBODY LIGHT CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 128PRO B 130THR B 129PRO B 158 | SO4 B 228 (-3.7A)NoneNoneNone | 1.35A | 1dsdC-3i75B:undetectable | 1dsdC-3i75B:9.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3i75 | ANTIBODY LIGHT CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 129PRO B 158THR B 128PRO B 130 | NoneNoneSO4 B 228 (-3.7A)None | 1.29A | 1dsdC-3i75B:undetectable | 1dsdC-3i75B:9.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3liz | 4C3 MONOCLONALANTIBODY HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 123PRO H 153THR H 122PRO H 124 | None | 1.34A | 1dsdC-3lizH:undetectable | 1dsdC-3lizH:5.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3nz8 | MOUSE ANTI V3ANTIBODY 7C8 FAB,HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR A 117PRO A 147THR A 116PRO A 118 | None | 1.35A | 1dsdC-3nz8A:undetectable | 1dsdC-3nz8A:7.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ra7 | FAB FRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 128PRO H 130THR H 129PRO H 159 | None | 1.28A | 1dsdC-3ra7H:undetectable | 1dsdC-3ra7H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ra7 | FAB FRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 129PRO H 159THR H 128PRO H 130 | None | 1.21A | 1dsdC-3ra7H:undetectable | 1dsdC-3ra7H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ria | MOUSE MONOCLONAL FABFRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR F 125PRO F 127THR F 126PRO F 156 | None | 1.27A | 1dsdC-3riaF:undetectable | 1dsdC-3riaF:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ria | MOUSE MONOCLONAL FABFRAGMENT, HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR F 126PRO F 156THR F 125PRO F 127 | None | 1.20A | 1dsdC-3riaF:undetectable | 1dsdC-3riaF:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sge | HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 119PRO H 149THR H 118PRO H 120 | None | 1.29A | 1dsdC-3sgeH:undetectable | 1dsdC-3sgeH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3uyr | ANTIBODY FAB HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 121PRO H 151THR H 120PRO H 122 | None | 1.34A | 1dsdC-3uyrH:undetectable | 1dsdC-3uyrH:6.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3v6o | MONOCLONAL ANTIBODY9F8 FAB FRAGMENTHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR C 122PRO C 124THR C 123PRO C 153 | None | 1.35A | 1dsdC-3v6oC:undetectable | 1dsdC-3v6oC:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3v6o | MONOCLONAL ANTIBODY9F8 FAB FRAGMENTHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR C 123PRO C 153THR C 122PRO C 124 | None | 1.29A | 1dsdC-3v6oC:undetectable | 1dsdC-3v6oC:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3v6z | FAB E6 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR A 127PRO A 157THR A 126PRO A 128 | None | 1.34A | 1dsdC-3v6zA:undetectable | 1dsdC-3v6zA:6.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dw2 | FAB FRAGMENT OFPRO-UPA ANTIBODYMAB-112 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 116PRO H 118THR H 117PRO H 141 | None | 1.35A | 1dsdC-4dw2H:undetectable | 1dsdC-4dw2H:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dw2 | FAB FRAGMENT OFPRO-UPA ANTIBODYMAB-112 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 141THR H 116PRO H 118 | None | 1.21A | 1dsdC-4dw2H:undetectable | 1dsdC-4dw2H:14.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4edx | HEAVY CHAIN OF FABOF MURINE ANTI-NGF (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 116PRO B 118THR B 117PRO B 149 | None | 1.33A | 1dsdC-4edxB:undetectable | 1dsdC-4edxB:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ij3 | HEAVY CHAIN OF FABFRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR C 121PRO C 123THR C 122PRO C 152 | None | 1.33A | 1dsdC-4ij3C:undetectable | 1dsdC-4ij3C:4.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ij3 | HEAVY CHAIN OF FABFRAGMENT (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR C 122PRO C 152THR C 121PRO C 123 | None | 1.28A | 1dsdC-4ij3C:undetectable | 1dsdC-4ij3C:4.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k24 | ANTI-UPAR ANTIBODY,HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 116PRO H 118THR H 117PRO H 147 | None | 1.10A | 1dsdC-4k24H:undetectable | 1dsdC-4k24H:7.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k24 | ANTI-UPAR ANTIBODY,HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 147THR H 116PRO H 118 | None | 1.05A | 1dsdC-4k24H:undetectable | 1dsdC-4k24H:7.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4l37 | SILKWORM STORAGEPROTEIN (Bombyx mori) |
PF00372(Hemocyanin_M)PF03722(Hemocyanin_N)PF03723(Hemocyanin_C) | 4 | THR A 8PRO A 10THR A 9PRO A 577 | None | 1.21A | 1dsdC-4l37A:undetectable | 1dsdC-4l37A:1.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lvn | NIMP.M7 FAB HEAVYCHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR C 124PRO C 154THR C 123PRO C 125 | None | 1.28A | 1dsdC-4lvnC:undetectable | 1dsdC-4lvnC:14.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mhh | H5M9 ANTIBODY, HEAVYCHAIN (IGG1) (Mus musculus) |
no annotation | 4 | THR H 116PRO H 118THR H 117PRO H 149 | None | 1.29A | 1dsdC-4mhhH:undetectable | 1dsdC-4mhhH:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mhh | H5M9 ANTIBODY, HEAVYCHAIN (IGG1) (Mus musculus) |
no annotation | 4 | THR H 117PRO H 149THR H 116PRO H 118 | None | 1.27A | 1dsdC-4mhhH:undetectable | 1dsdC-4mhhH:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odw | A6 FAB (IGG2B) HEAVYCHAIN (Mus musculus) |
no annotation | 4 | THR H 117PRO H 146THR H 116PRO H 118 | None | 1.34A | 1dsdC-4odwH:undetectable | 1dsdC-4odwH:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4onf | 3D6 FAB ANTIBODYHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 122PRO H 124THR H 123PRO H 153 | None | 1.33A | 1dsdC-4onfH:undetectable | 1dsdC-4onfH:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4onf | 3D6 FAB ANTIBODYHEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 123PRO H 153THR H 122PRO H 124 | None | 1.29A | 1dsdC-4onfH:undetectable | 1dsdC-4onfH:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4p3c | HEAVY CHAIN FABFRAGMENT OF ANTIBODYLEM-2/15 (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 122PRO H 152THR H 121PRO H 123 | None | 1.34A | 1dsdC-4p3cH:undetectable | 1dsdC-4p3cH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6i | HEAVY CHAIN OFMURINE 2D5 FAB (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 116PRO B 118THR B 117PRO B 147 | None | 1.35A | 1dsdC-4q6iB:undetectable | 1dsdC-4q6iB:5.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q6i | HEAVY CHAIN OFMURINE 2D5 FAB (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 117PRO B 147THR B 116PRO B 118 | None | 1.28A | 1dsdC-4q6iB:undetectable | 1dsdC-4q6iB:5.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qex | ANTIBODY HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 116PRO H 146THR H 115PRO H 117 | None | 1.30A | 1dsdC-4qexH:undetectable | 1dsdC-4qexH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qti | ANTI-UPAR ANTIBODY,HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 126PRO H 156THR H 125PRO H 127 | None | 1.35A | 1dsdC-4qtiH:undetectable | 1dsdC-4qtiH:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rgn | 14G8 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 124PRO B 154THR B 123PRO B 125 | None | 1.33A | 1dsdC-4rgnB:undetectable | 1dsdC-4rgnB:12.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uom | FAB FRAGMENT HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 119PRO H 121THR H 120PRO H 150 | None | 1.34A | 1dsdC-4uomH:undetectable | 1dsdC-4uomH:7.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4uom | FAB FRAGMENT HEAVYCHAIN (Homo sapiens) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 120PRO H 150THR H 119PRO H 121 | None | 1.27A | 1dsdC-4uomH:undetectable | 1dsdC-4uomH:7.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zxb | FAB 83-7 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR A 122PRO A 152THR A 121PRO A 123 | None | 1.32A | 1dsdC-4zxbA:undetectable | 1dsdC-4zxbA:7.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5b6f | ANTI-LEUKOTRIENE C4MONOCLONAL ANTIBODYIMMUNOGLOBULINGAMMA1 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 141PRO B 171THR B 140PRO B 142 | None | 1.31A | 1dsdC-5b6fB:undetectable | 1dsdC-5b6fB:3.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5c0n | FAB CA33 HEAVY CHAIN (Oryctolaguscuniculus) |
no annotation | 4 | THR H 124PRO H 154THR H 123PRO H 125 | None | 1.31A | 1dsdC-5c0nH:undetectable | 1dsdC-5c0nH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5do2 | 4C2 HEAVY CHAIN (Mus musculus) |
no annotation | 4 | THR H 120PRO H 150THR H 119PRO H 121 | None | 1.33A | 1dsdC-5do2H:undetectable | 1dsdC-5do2H:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5foe | GDP-FUCOSE PROTEINO-FUCOSYLTRANSFERASE2,THROMBOSPONDIN-1 (Caenorhabditiselegans;Homo sapiens) |
PF00090(TSP_1)PF10250(O-FucT) | 4 | THR A 304PRO A 303THR A 308PRO A 306 | None | 1.23A | 1dsdC-5foeA:undetectable | 1dsdC-5foeA:2.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5foe | GDP-FUCOSE PROTEINO-FUCOSYLTRANSFERASE2,THROMBOSPONDIN-1 (Caenorhabditiselegans;Homo sapiens) |
PF00090(TSP_1)PF10250(O-FucT) | 4 | THR A 308PRO A 306THR A 304PRO A 303 | None | 1.25A | 1dsdC-5foeA:undetectable | 1dsdC-5foeA:2.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5foh | POLYSACCHARIDEMONOOXYGENASE (Neurosporacrassa) |
PF03443(Glyco_hydro_61) | 4 | THR A 46PRO A 48THR A 47PRO A 23 | None | 1.09A | 1dsdC-5fohA:undetectable | 1dsdC-5fohA:6.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5foh | POLYSACCHARIDEMONOOXYGENASE (Neurosporacrassa) |
PF03443(Glyco_hydro_61) | 4 | THR A 47PRO A 23THR A 46PRO A 48 | None | 1.15A | 1dsdC-5fohA:undetectable | 1dsdC-5fohA:6.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hdq | FAB HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 117PRO H 147THR H 116PRO H 118 | None | 1.33A | 1dsdC-5hdqH:undetectable | 1dsdC-5hdqH:6.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jor | FAB14.22 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 116PRO B 118THR B 117PRO B 147 | None | 1.19A | 1dsdC-5jorB:undetectable | 1dsdC-5jorB:5.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jor | FAB14.22 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 117PRO B 147THR B 116PRO B 118 | None | 1.15A | 1dsdC-5jorB:undetectable | 1dsdC-5jorB:5.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l56 | PLEXIN-A1 (Mus musculus) |
PF01403(Sema)PF01437(PSI)PF01833(TIG) | 4 | THR A 187PRO A 197THR A 198PRO A 188 | None | 1.33A | 1dsdC-5l56A:undetectable | 1dsdC-5l56A:1.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l56 | PLEXIN-A1 (Mus musculus) |
PF01403(Sema)PF01437(PSI)PF01833(TIG) | 4 | THR A 198PRO A 188THR A 187PRO A 197 | None | 1.26A | 1dsdC-5l56A:undetectable | 1dsdC-5l56A:1.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ldn | ANTIBODY (Mus musculus) |
no annotation | 4 | THR H 120PRO H 150THR H 119PRO H 121 | None | 1.30A | 1dsdC-5ldnH:undetectable | 1dsdC-5ldnH:13.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5myx | FAB C#24 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR B 119PRO B 149THR B 118PRO B 120 | None | 1.32A | 1dsdC-5myxB:undetectable | 1dsdC-5myxB:7.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5o2v | NUCLEOLYSIN TIA-1ISOFORM P40 (Homo sapiens) |
PF00076(RRM_1) | 4 | THR A 82PRO A 84THR A 83PRO A 6 | None | 1.22A | 1dsdC-5o2vA:undetectable | 1dsdC-5o2vA:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ocy | ACPA E4 FAB FRAGMENT- HEAVY CHAIN (Homo sapiens) |
no annotation | 4 | THR H 124PRO H 154THR H 123PRO H 125 | None | 1.34A | 1dsdC-5ocyH:undetectable | 1dsdC-5ocyH:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vlp | FAB7G7 HEAVY CHAIN (Mus musculus) |
PF07654(C1-set)PF07686(V-set) | 4 | THR H 128PRO H 158THR H 127PRO H 129 | None | 1.32A | 1dsdC-5vlpH:undetectable | 1dsdC-5vlpH:6.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vxr | MAB24 VARIABLE HEAVYCHAIN,MAB24 VARIABLEHEAVY CHAIN (Mus musculus) |
no annotation | 4 | THR H 123PRO H 153THR H 122PRO H 124 | None | 1.31A | 1dsdC-5vxrH:undetectable | 1dsdC-5vxrH:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xjm | FABH (Mus musculus) |
no annotation | 4 | THR H 123PRO H 125THR H 124PRO H 154 | None | 1.35A | 1dsdC-5xjmH:undetectable | 1dsdC-5xjmH:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xjm | FABH (Mus musculus) |
no annotation | 4 | THR H 124PRO H 154THR H 123PRO H 125 | None | 1.26A | 1dsdC-5xjmH:undetectable | 1dsdC-5xjmH:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6aun | PLA2G6, IPLA2BETA (Cricetulusgriseus) |
no annotation | 4 | THR A 345PRO A 353THR A 352PRO A 346 | None | 1.32A | 1dsdC-6aunA:undetectable | 1dsdC-6aunA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bpd | MONOCLONAL ANTIBODY10B12 FAB HEAVYCHAIN (Mus musculus) |
no annotation | 4 | THR A 142PRO A 172THR A 141PRO A 143 | None | 1.32A | 1dsdC-6bpdA:undetectable | 1dsdC-6bpdA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bzy | 22D11 HEAVY CHAIN (Mus musculus) |
no annotation | 4 | THR H 117PRO H 147THR H 116PRO H 118 | None | 1.34A | 1dsdC-6bzyH:undetectable | 1dsdC-6bzyH:undetectable |